Most Popular

Employment Protection and Corporate Cash Holdings: Evidence from China’s Labor Contract Law

Chenyu Cui, Kose John, Jiaren Pang, Haibin Wu, Oct 13, 2021

We examine whether and how employment protection influences corporate cash holdings using Chinese firm-level data. Our empirical results show that labor-intensive firms in China significantly increased their cash holdings following the enactment of China’s Labor Contract Law. Further analyses suggest that the results are generally consistent with a “labor adjustment costs” channel: employment protection...

How Does Salient Academic Rank Affect Student Performance? Insights from a Chinese Middle School Study

Rigissa Megalokomomou, Yi Zhang, Nov 20, 2024

This article reveals interesting insights into the effects and mechanisms of achievement rank when it becomes salient to students and their parents.

Peer Effects, Political Competition, and Ecological Efficiency

Xudong Chen, Bihong Huang, Yantuan Yu, Jul 29, 2020

This study examines the impacts of political competition on eco-efficiency. We first develop a theoretical model in which local government officials compete against each other to maximize their own political score. We find that after an initial stage of decline, eco-efficiency eventually increases once environmental performance becomes a meaningful component of local government officials’ annual assessment. These theoretical predictions are corroborated...

Growing Apart: Declining Within- and Across-Village Risk Sharing in Rural China

Orazio Attanasio, Costas Meghir, Corina Mommaerts, and Yu Zheng , May 25, 2022

China has embarked on an ambitious campaign to close income gaps, address regional inequality and unfair social welfare provision, and make solid progress toward common prosperity by 2035. This marks a shift in focus from overall growth to promoting equitable and balanced growth.

Improving Regulation for Innovation: Evidence from China’s Pharmaceutical Industry

Ruixue Jia, Xiao Ma, Jianan Yang, Yiran Zhang, Mar 06, 2024

In 2015, China revamped its pharmaceutical regulations, drawing inspiration from the US, to accelerate drug approvals. Using data at the drug and firm levels during 2011–2021, this study reveals three key outcomes.